Exposure to drugs with anticholinergic and/or sedative properties in the elderly is common despite the known risks of falls, cognitive and functional decline. First, a study based on data from the 2023 SNDS was conducted to assess the prevalence of consumption of these drugs. In order to reduce anticholinergic and sedative drug exposure, the DIOPAS study was funded via a PREPS 2023 and aims to assess the impact of a multidisciplinary and participatory pathway for deprescribing anticholinergic and/or sedative drugs in elderly outpatients. The DIOPAS study is composed of 2 phases: a co-construction phase with healthcare professionals from CPTS, hospitals and patients (participatory research); and an evaluation phase (randomized controlled clinical trial in CPTS cluster).
Speaker : Teddy NOVAIS PRATICIEN HOSPITALIER - PH
Discussion partner : Anne-Marie SCHOTT
